InvestorsHub Logo
Followers 1
Posts 56
Boards Moderated 0
Alias Born 07/10/2003

Re: None

Friday, 02/25/2005 6:44:31 PM

Friday, February 25, 2005 6:44:31 PM

Post# of 82595


I feel were still VERY much in the mix with Bio... why would we still be on there supervisory board ? The time isnt right for the deal to go threw at this point . Our SP is to low and would kill us at this point . JMO any one else care to take a guess ? Im all ears .PS I wont be able to read any more post tonight .I plan on trying out some Blue goose :P and should slowly slip into a coma for the next 2 days !!! Hopfully Monday will bring us new news from our Co.
Hummer





supervisory board





Prof. Axel Kleemann, PhD, formerly a member of the executive board of ASTA Medica, where he was responsible for R&D, production, engineering, and drug safety (Chairman)

Timo Hercegfi, Partner, Heidelberg Innovation (Vice Chairman)

Richard Gabriel, MS, MBA, CEO and President of DNAPrint genomics Inc., FL, USA

Hector J. Gomez, MD, PhD, Chairman and Chief Medical Officer of DNAPrint genomics Inc., FL, USA

Ulrich Granzer, MD, former head of regulatory affairs at Glaxo Welcome, head of drug registration at BASF Pharma, and Vice President Global Regulatory Affairs at Bayer AG

Prof. Bernd Wetzel, PhD, former head of world-wide research and non-clinical development at Boehringer Ingelheim